Dingcong, Kaye Rose M.

HRN: 27-22-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2025
CEFTRIAXONE 1G (VIAL)
05/31/2025
06/06/2025
IV
1 Gm
BID
Q12
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines